Table 4.
Age- and Sex-Standardized Incidence Rates of Specific Hematologic Malignancies in Patients With AMI
| Type of Hematologic Malignancy | Observed | Expected | Person-Years | SIR (95% CI) |
|---|---|---|---|---|
| Non-Hodgkin lymphoma | 328 | 123.1 | 864,486 | 2.66 (2.38-2.95) |
| Myeloid leukemia | 147 | 56.5 | 865,166 | 2.60 (2.18-3.02) |
| Multiple myeloma | 206 | 49.5 | 865,058 | 4.16 (3.60-4.73) |
| Myeloproliferative neoplasms | 172 | 30.9 | 864,646 | 5.57 (4.74-6.40) |
| Myelodysplastic syndrome | 133 | 28.9 | 865,201 | 4.60 (3.82-5.38) |
| Malignant immunoproliferative diseases | 43 | 25.1 | 865,342 | 1.71 (1.20-2.22) |
| Lymphoid leukemia | 29 | 12.8 | 865,421 | 2.27 (1.45-3.10) |
| Hodgkin lymphoma | 27 | 5.5 | 865,410 | 4.95 (3.09-6.82) |
| Leukemia, unspecified | 47 | 9.7 | 865,353 | 4.86 (3.47-6.25) |
AMI = acute myocardial infarction; SIR = standardized incidence ratio.